US 10485869
Etanercept formulations stabilized with meglumine
granted A61KA61K38/1793A61K39/39591
Quick answer
US patent 10485869 (Etanercept formulations stabilized with meglumine) held by Coherus BioSciences, Inc. expires Mon Nov 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Coherus BioSciences, Inc.
- Grant date
- Tue Nov 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K38/1793, A61K39/39591